Corrigendum to "Comparison of glucagons like peptide-1 receptor agonists and dipeptidyl peptide-4 inhibitors regarding cardiovascular safety and mortality in type 2 diabetes mellitus: A network meta-analysis" [Prim. Care Diabetes 15 (April (2)) (2021) 227-233]

Prim Care Diabetes. 2021 Apr 7:S1751-9918(21)00045-0. doi: 10.1016/j.pcd.2021.04.001. Online ahead of print.NO ABSTRACTPMID:33839056 | DOI:10.1016/j.pcd.2021.04.001

Source: Primary Care - April 11, 2021 Category: Primary Care Authors: Jing Hu Liyun Chen Source Type: research